{"id":"W3082341997","doi":"10.1093/eurheartj/ehaa617","title":"Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Biosense Webster; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Medicure; Boston Scientific Corporation; Deutsche Herzstiftung; Bristol-Myers Squibb; AstraZeneca; Servier; Amgen; Pfizer; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Edoxaban; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Acute coronary syndrome; Cardiology; Atrial fibrillation; Myocardial infarction; Hazard ratio; Clinical endpoint; Randomized controlled trial; Warfarin; Confidence interval; Dabigatran","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002251401,0.001377788,0.002548174,0.0002043504,0.0002638836,0.001346841,0.0005985872,0.001123739,0.002759698],"category_scores_gemma":[0.002937054,0.0004296979,0.003263788,0.0003626328,0.0004950934,0.0006961029,0.0006204022,0.001784933,0.000411241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004146462,"about_ca_system_score_gemma":0.0005134901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006046451,"about_ca_topic_score_gemma":0.001519172,"domain_scores_codex":[0.9987227,0.0007593791,0.0001117915,0.0001861681,0.0001021019,0.0001177195],"domain_scores_gemma":[0.9984953,0.000436142,0.0004605626,0.0001990823,0.000105104,0.0003038014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9661936,0.001572701,0.01542864,0.0009472182,0.00626616,0.00009736134,0.00006080145,0.00040326,0.001200633,0.0001769947,0.0006895791,0.006963051],"study_design_scores_gemma":[0.8268375,0.06398138,0.08589219,0.0002681908,0.01659976,0.0003604272,0.0001629725,0.001929482,0.001107242,0.000767291,0.002014712,0.00007898937],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912953,0.00464729,0.0003676732,0.0003485414,0.0001565351,0.0007176068,0.001034907,0.00002585272,0.00140628],"genre_scores_gemma":[0.9932887,0.001494015,0.0005389663,0.0004384329,0.0002573394,0.0006378583,0.002517534,0.000009629592,0.0008176625],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002759698,"threshold_uncertainty_score":0.01190668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04935026771025512,"score_gpt":0.3166852441811516,"score_spread":0.2673349764708964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}